Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)Tax Rate
Others
Ratios

NewGenIvf (NIVF) Operating Expenses: 2021-2024

Historic Operating Expenses for NewGenIvf (NIVF) over the last 4 years, with Dec 2024 value amounting to $3.0 million.

  • NewGenIvf's Operating Expenses fell 508.19% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $3.0 million for FY2024, which is 82.21% up from last year.
  • Per NewGenIvf's latest filing, its Operating Expenses stood at $3.0 million for FY2024, which was up 82.21% from $1.6 million recorded in FY2023.
  • NewGenIvf's 5-year Operating Expenses high stood at $3.0 million for FY2024, and its period low was $826,022 during FY2021.
  • Over the past 3 years, NewGenIvf's median Operating Expenses value was $1.6 million (recorded in 2023), while the average stood at $1.9 million.
  • In the last 5 years, NewGenIvf's Operating Expenses tumbled by 37.90% in 2022 and then surged by 82.21% in 2024.
  • Over the past 4 years, NewGenIvf's Operating Expenses (MRY) stood at $826,022 in 2021, then surged by 37.90% to $1.1 million in 2022, then skyrocketed by 43.94% to $1.6 million in 2023, then surged by 82.21% to $3.0 million in 2024.
  • Its last three reported values are $3.0 million in FY2024, $1.6 million for FY2023, and $1.1 million during FY2022.